Company research / GNTA

Genenta Science S.p.A. (GNTA)

Build a valuation ↗↓ Download CSV

CIK 0001838716

Key ratios (year ended 2025-12-31)

-29.9%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 6-K · 2026-09-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Operating Income	-6.60M EUR	-9.76M EUR	-11.73M EUR	-11.04M EUR	-5.69M EUR	-5.59M EUR	-4.62M EUR	—
Net Income	-6.53M EUR	-8.91M EUR	-11.65M EUR	-8.48M EUR	-5.53M EUR	-5.59M EUR	-4.60M EUR	—
EPS (Diluted)	-0.33 EUR	-0.49 EUR	-0.64 EUR	-0.47 EUR	-0.37 EUR	—	—	—
Total Assets	31.89M EUR	14.82M EUR	22.35M EUR	33.44M EUR	40.03M EUR	17.50M EUR	—	—
Shareholders' Equity	21.84M EUR	12.50M EUR	20.43M EUR	31.14M EUR	38.86M EUR	15.15M EUR	18.85M EUR	7.93M EUR
Cash & Equivalents	5.53M EUR	4.58M EUR	3.69M EUR	29.79M EUR	37.24M EUR	15.47M EUR	—	—
Operating Cash Flow	-6.87M EUR	-6.24M EUR	-11.21M EUR	-7.42M EUR	-6.96M EUR	-6.04M EUR	-2.49M EUR	—
Capital Expenditures	7.6K EUR	4.5K EUR	13.8K EUR	27.1K EUR	9.0K EUR	20.9K EUR	—	—
Shares Outstanding	23.43M	18.29M	18.22M	18.22M	18.22M	18.22M	—	—
Weighted Average Diluted Shares	19.71M	18.27M	18.22M	18.22M	15.08M	—	—	—
EPS (Basic)	—	—	-0.64 EUR	-0.47 EUR	-0.37 EUR	—	—	—